The Female Health Company / Veru Healthcare to Host Investor Conference Call on Thursday, March 9th
March 03 2017 - 1:06PM
The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today
announced that it will host a conference call to update investors
on the Company’s product commercialization and drug development
progress on Thursday, March 9, 2017 at 10:30 a.m. Eastern Time
(ET).
The conference call will be available to interested parties by
dialing 1-877-883-0383 from the U.S. or 1-412-902-6506 from
international locations, participant entry number for all
9649925.
A replay of the conference call will be available beginning on
Tuesday, March 14, 2017 through Tuesday, March 21, 2017, by dialing
1-877-344-7529 (international callers dial 1-412-317-0088) and
entering the replay access code 10102781. After Tuesday,
March 21, 2017, the replay of the call will be available on the
Company’s website at www.fhcinvestor.com.
About The Female Health Company / Veru
HealthcareThe Female Health Company / Veru Healthcare is a
pharmaceutical and medical device company, with a focus on the
development and commercialization of pharmaceuticals that qualify
for the FDA's 505(b)(2) accelerated regulatory approval pathway as
well as the 505(b)(1) pathway. The Company does business both
as "Veru Healthcare" and as "The Female Health Company" and is
organized as follows:
- Veru Healthcare manages the Pharmaceuticals Division, which
develops and commercializes pharmaceutical products for men's and
women's health and oncology.
- Veru Healthcare manages the Consumer Health / Medical Devices
Division, which is focused on commercializing sexual healthcare
products and devices for the consumer market, including the
Company's FC2 Female Condom® in the consumer health products sector
and PREBOOST® medicated individual wipes, which are a male genital
desensitizing drug product that helps in the prevention of
premature ejaculation.
- The Female Health Company manages the Global Public Health
Division, which is focused on the global public health sector FC2
business. This division markets the Company’s Female Condom
(FC2) to entities, including ministries of health, government
health agencies, U.N. agencies, nonprofit organizations and
commercial partners, that work to support and improve the lives,
health and well-being of women around the world.
More information about The Female Health Company and its
products can be found at www.femalehealth.com,
www.veruhealthcare.com and www.femalecondom.org. For
corporate and investor-related information about the Company,
please visit www.FHCinvestor.com.
Contact:
Kevin Gilbert: 312-366-2633
Veru (NASDAQ:VERU)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veru (NASDAQ:VERU)
Historical Stock Chart
From Apr 2023 to Apr 2024